Dr. Mark P Atlas, MD
Claim this profileThe Steven and Alexandra Cohen Children's Medical Center of New York
Area of expertise
Brain Tumor
Mark P Atlas, MD has run 4 trials for Brain Tumor. Some of their research focus areas include:
Low Grade Glioma
Mark P Atlas, MD has run 3 trials for Low Grade Glioma. Some of their research focus areas include:
Affiliated Hospitals
The Steven And Alexandra Cohen Children's Medical Center Of New York
Cohen Children's Medical Center Of New York
Clinical Trials Mark P Atlas, MD is currently running
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting
2 awards
Phase 3
Sodium Thiosulfate
for Hearing Loss in Medulloblastoma
This phase III trial tests two hypotheses in patients with low-risk and average-risk medulloblastoma. Medulloblastoma is a type of cancer that occurs in the back of the brain. The term, risk, refers to the chance of the cancer coming back after treatment. Subjects with low-risk medulloblastoma typically have a lower chance of the cancer coming back than subjects with average-risk medulloblastoma. Although treatment for newly diagnosed average-risk and low-risk medulloblastoma is generally effective at treating the cancer, there are still concerns about the side effects of such treatment. Side effects or unintended health conditions that arise due to treatment include learning difficulties, hearing loss or other issues in performing daily activities. Standard therapy for newly diagnosed average-risk or low-risk medulloblastoma includes surgery, radiation therapy, and chemotherapy (including cisplatin). Cisplatin may cause hearing loss as a side effect. In the average-risk medulloblastoma patients, this trial tests whether the addition of sodium thiosulfate (STS) to standard of care chemotherapy and radiation therapy reduces hearing loss. Previous studies with STS have shown that it may help reduce or prevent hearing loss caused by cisplatin. In the low-risk medulloblastoma patients, the study tests whether a less intense therapy (reduced radiation) can provide the same benefits as the more intense therapy. The less intense therapy may cause fewer side effects. Radiation therapy uses high energy x-rays to kill tumor cells and shrink tumors. Cisplatin is in a class of medications known as platinum-containing compounds. It works by killing, stopping or slowing the growth of cancer cells. The overall goals of this study are to see if giving STS along with standard treatment (radiation therapy and chemotherapy) will reduce hearing loss in medulloblastoma patients and to compare the overall outcome of patients with medulloblastoma treated with STS to patients treated without STS on a previous study in order to make sure that survival and recurrence of tumor is not worsened.
Recruiting
3 awards
Phase 3
More about Mark P Atlas, MD
Clinical Trial Related
6 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Mark P Atlas, MD has experience with
- Radiation Therapy
- Vincristine
- Carboplatin
- Cyclophosphamide
- Lomustine
- Selumetinib
Breakdown of trials Mark P Atlas, MD has run
Brain Tumor
Low Grade Glioma
Diffuse Hemispheric Glioma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark P Atlas, MD specialize in?
Mark P Atlas, MD focuses on Brain Tumor and Low Grade Glioma. In particular, much of their work with Brain Tumor has involved BRAF negative patients, or patients who are Stage I.
Is Mark P Atlas, MD currently recruiting for clinical trials?
Yes, Mark P Atlas, MD is currently recruiting for 3 clinical trials in New Hyde Park New York. If you're interested in participating, you should apply.
Are there any treatments that Mark P Atlas, MD has studied deeply?
Yes, Mark P Atlas, MD has studied treatments such as Radiation Therapy, Vincristine, Carboplatin.
What is the best way to schedule an appointment with Mark P Atlas, MD?
Apply for one of the trials that Mark P Atlas, MD is conducting.
What is the office address of Mark P Atlas, MD?
The office of Mark P Atlas, MD is located at: The Steven and Alexandra Cohen Children's Medical Center of New York, New Hyde Park, New York 11040 United States. This is the address for their practice at the The Steven and Alexandra Cohen Children's Medical Center of New York.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.